The turnover of the company UNIMED has increased by 4% to 42.5 million dinars in the first half of the current year.
This business performance is achieved thanks to the strong rise in exports which have increased by 12% to 24.8 million dinars, against 22 million dinars on June 30, 2021.
The officinal sales went up 5% to 17.6 million dinars, against 16.8 million on June 30, 2021.
As for the production in units (ampoules, vials, syringes, bags), it amounts to 75.7 million units during the first half of 2022.
In addition, the investments (intangible & tangible) made during the first half of 2022, amount to 2.7 million dinars.
The value of the realized investments is in accordance with the investment plan of extension planned by the company.
The outstanding long-term debt as of June 30, 2022 amounts to 28.6 million dinars, against 21.9 million dinars at the end of December 2021, while the outstanding short-term debt amounts to 8.7 million dinars.
The latter are composed of maturities within one year on bank credits for 6.2 million dinars and on leasing credits for 0.2 million as well as management credits for 2.3 million.
